# Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/epithelial-to-mesenchymal-transition-is-a-cause-of-both-intrinsic-and-acquired/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuta Adachi,Kentaro Ito,Yuko Hayashi,Ryo Kimura,Tuan Zea Tan,Rui Yamaguchi,Hiromichi Ebi |
| Citations | 246 |
| DOI | 10.1158/1078-0432.ccr-20-2077 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3084225156 |
| PMID | 32900796 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Rui Yamaguchi](https://scholariq.org/researchers/rui-yamaguchi/)
- [Hiromichi Ebi](https://scholariq.org/researchers/hiromichi-ebi/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)

## Paper topics

- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.